This retrospective study aims to evaluate the long-term efficacy and urinary toxicity of LDR-brachytherapy for localized prostate cancer. 235 primary prostate cancer patients treated with ...

In Meraouna et al.'s study, the failure-free survival rate was 66% at 3 years of follow-up. Regarding treatment-related morbidities, 12.3% of patients experienced grade 3 genitourinary (GU) toxicity, ...

A nurse-led mobile healthcare clinic identified a high proportion of clinically significant prostate cancers among men from ...

The incidence of late grade 2 or greater GU toxicity at 5 years was 12.5% among those who did experience acute toxicity vs 7.5% among those who did not. “MPS2 could potentially improve the health of ...

After diagnosis, the participants went on to receive additional care and/or prostate cancer treatment: 25 (26.6%) were managed with active surveillance. 2 (2.1%) were treated with cryotherapy, which ...

When prostate cancer metastasizes, spreads outside of the prostate itself, it typically affects the structures in its immediate vicinity. Structures near the prostate likely to be involved include ...

Early prostate cancer usually causes no symptoms, but can include blood in the urine or semen. The outlook is often excellent, especially if doctors diagnose it in the early stages. Prostate ...

Cases of prostate cancer are on the rise in California, according to new research. A study by UC San Francisco (UCSF) included nearly 388,000 men who had prostate cancer between 2004 and 2021.

A diet high in omega-3 fatty acids and low in omega-6 fatty acids, taken with fish oil, reduced the Ki-67 index in men with prostate cancer on active surveillance. From the death of folk music star ...

The following is a summary of “Brachytherapy ... Lung Cancer: A Human Cadaveric Feasibility Pilot,” published in the January 2025 issue of Oncology by Latifi et al. This study investigates the ...